Glucagon raises blood sugar levels, so by reducing its release, semaglutide helps keep blood sugar from getting too high
95% CI 1.05 to 1.44), with longer treatment periods associated with a greater risk [90]
Mounjaro (tirzepatide) is a relatively new medication licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
"In summary, semaglutide, 1 mg weekly, is an effective therapy for MASLD in PWH and shows evidence of broader cardiometabolic benefit," the authors write
doi: 10.1042/bsr20180890 195 ZhouYLiSChenPYangBYangJLiuRet al
First-time self-injectors who want live guidance